Return On Equity of Enliven Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Enliven Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Enliven Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -25%, a 16% increase year-over-year.
  • Enliven Therapeutics, Inc. annual Return On Equity for 2024 was -29%, a 9.8% decline from 2023.
  • Enliven Therapeutics, Inc. annual Return On Equity for 2023 was -27%, a 145% decline from 2022.
  • Enliven Therapeutics, Inc. annual Return On Equity for 2022 was 59%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Enliven Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -25% +4.6% +16% 01 Jul 2025 30 Sep 2025
Q2 2025 -29% +0.16% +0.55% 01 Apr 2025 30 Jun 2025
Q1 2025 -32% -3% -10% 01 Jan 2025 31 Mar 2025
Q4 2024 -29% -2.6% -9.8% 01 Oct 2024 31 Dec 2024
Q3 2024 -29% +3.2% +9.9% 01 Jul 2024 30 Sep 2024
Q2 2024 -29% +19% +40% 01 Apr 2024 30 Jun 2024
Q1 2024 -29% +170% +86% 01 Jan 2024 31 Mar 2024
Q4 2023 -27% -86% -145% 01 Oct 2023 31 Dec 2023
Q3 2023 -33% -61% -214% 01 Jul 2023 30 Sep 2023
Q2 2023 -48% -191% -134% 01 Apr 2023 30 Jun 2023
Q1 2023 -199% -68% -52% 01 Jan 2023 31 Mar 2023
Q4 2022 59% +109% 01 Oct 2022 31 Dec 2022
Q3 2022 29% +117% 01 Jul 2022 30 Sep 2022
Q2 2022 143% +231% 01 Apr 2022 30 Jun 2022
Q1 2022 -131% -61% -89% 01 Jan 2022 31 Mar 2022
Q4 2021 -50% +7.6% +13% 01 Oct 2021 31 Dec 2021
Q3 2021 -88% -31% -53% 01 Jul 2021 30 Sep 2021
Q2 2021 -88% +16% +15% 01 Apr 2021 30 Jun 2021
Q1 2021 -69% -570% -114% 01 Jan 2021 31 Mar 2021
Q4 2020 -58% -118% -197% 01 Oct 2020 31 Dec 2020
Q3 2020 -58% 01 Jul 2020 30 Sep 2020
Q2 2020 -104% 01 Apr 2020 30 Jun 2020
Q1 2020 500% 01 Jan 2020 31 Mar 2020
Q4 2019 60% 01 Oct 2019 31 Dec 2019

Enliven Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -29% -2.6% -9.8% 01 Jan 2024 31 Dec 2024
2023 -27% -86% -145% 01 Jan 2023 31 Dec 2023
2022 59% +109% 01 Jan 2022 31 Dec 2022
2021 -50% +7.6% +13% 01 Jan 2021 31 Dec 2021
2020 -58% -118% -197% 01 Jan 2020 31 Dec 2020
2019 60% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.